U.S. drugmaker Clovis files for Chapter 11 bankruptcy

Clovis Oncology

12/12/2022 05:31

Dec 12 (Reuters) - U.S. drugmaker Clovis Oncology Inc
 CLVS.O  on Sunday filed for bankruptcy in Delaware, hit by a
fall in its cancer drug sales and challenges in raising
additional capital.
    In a court filing at the U.S. Bankruptcy Court for the
District of Delaware, Clovis estimated its assets were in range
of $100 million to $500 million, while liabilities were
between$500 million to $1 billion. 
 (Reporting by Maria Ponnezhath in Bengaluru; Nivedita
Bhattacharjee)
 ((Maria.Ponnezhath@thomsonreuters.com; +91 8061822749;))